Over Rs 2 Cr Semaglutide Theft at Dr Reddy's Srikakulam Unit, Staff Among 8 Arrested

The gang reportedly sold the diverted API to unauthorized buyers in major metros like Mumbai and Chennai. The culprits allegedly packed the stolen semaglutide in food delivery containers to avoid detection while transporting it out of the premises.

Initial reports suggest that multiple kilograms of the product had already been trafficked before the matter came to light. Based on internal audits and inventory checks, the pharmaceutical company lodged a formal complaint, prompting police to launch an investigation.

“They smuggled the powder in food delivery containers to avoid suspicion and sold it in cities like Mumbai and Chennai,” the police added.

Dr. Reddy’s Laboratories has not yet released a formal public statement on the matter. However, TOI reports that industry insiders say that such internal breaches in high-value API manufacturing facilities underscore the need for enhanced surveillance and stricter material accountability protocols.

The pharmaceutical industry, particularly those involved in GLP-1 agonist API production, has taken note of the incident, as semaglutide continues to remain in high global demand and commands a premium price across regulated and semi-regulated markets.

Law enforcement authorities are continuing further investigation, and more arrests are expected in connection with the illegal diversion of pharmaceutical-grade semaglutide.